Version 1
: Received: 24 June 2021 / Approved: 25 June 2021 / Online: 25 June 2021 (12:09:51 CEST)
How to cite:
Goshu, B.T. Molecular Modulators of Adipogenesis as Treatment Options for Obesity. Preprints2021, 2021060620. https://doi.org/10.20944/preprints202106.0620.v1
Goshu, B.T. Molecular Modulators of Adipogenesis as Treatment Options for Obesity. Preprints 2021, 2021060620. https://doi.org/10.20944/preprints202106.0620.v1
Goshu, B.T. Molecular Modulators of Adipogenesis as Treatment Options for Obesity. Preprints2021, 2021060620. https://doi.org/10.20944/preprints202106.0620.v1
APA Style
Goshu, B.T. (2021). Molecular Modulators of Adipogenesis as Treatment Options for Obesity. Preprints. https://doi.org/10.20944/preprints202106.0620.v1
Chicago/Turabian Style
Goshu, B.T. 2021 "Molecular Modulators of Adipogenesis as Treatment Options for Obesity" Preprints. https://doi.org/10.20944/preprints202106.0620.v1
Abstract
Abstract: As a risk factor, obesity is a threat to human well-being and related metabolic disorders such as diabetes mellitus and dyslipidemia. adipogenesis is defined as the proliferation and maturation of adipocyte predecessor cells to adipocyte. As the adipogenesis process decides adipocyte production, it may be considered a therapeutic target for obesity and obesity-related disorders. White adipose tissue abnormal expansion increases the size and number of adipocytes. For that reason, this review aims to spot the molecular mechanisms implicated in adipogenesis that lead to application in the therapeutic targets. Keywords: adipogenesis, signaling pathways, anti-obesity treatment, obesity
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
